Neutralising antibody escape of SARS‐CoV‐2 spike protein: risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
The Spike protein is the target of both antibody‐based therapeutics (convalescent plasma,
polyclonal serum, monoclonal antibodies) and vaccines. Mutations in Spike could affect …
polyclonal serum, monoclonal antibodies) and vaccines. Mutations in Spike could affect …
[HTML][HTML] COVID-19 vaccination acceptance and its associated factors among cancer patients in Tunisia
Background: Vaccination is the most effective way to fight the COVID-19 pandemic and to
protect people who have a higher risk of developing severe illness and death from COVID …
protect people who have a higher risk of developing severe illness and death from COVID …
[HTML][HTML] Quantifying knowledge synchronization with the network-driven approach
Humans acquire and accumulate knowledge through language usage and eagerly
exchange their knowledge for advancement. Although geographical barriers had previously …
exchange their knowledge for advancement. Although geographical barriers had previously …
COVID-19 transmission due to mass mobility before and after the largest festival in Bangladesh: An epidemiologic study
FN Rahman, AKMF Rahman… - … : The Journal of …, 2021 - journals.sagepub.com
Festivals traditionally result in mass public mobility from large cities to rural or semi-urban
areas in low-and middle-Income Countries (LMIC), which are inadequately prepared for …
areas in low-and middle-Income Countries (LMIC), which are inadequately prepared for …
[HTML][HTML] SARS‐CoV‐2 B. 1.1. 7 reinfection after previous Covid‐19 in two immunocompetent italian patients
To date, only one case of SARS‐COV‐2 B. 1.1. 7 reinfection has been reported. 1 We report
here two more such reinfection cases in Lombardy residents that, nevertheless the ECDC …
here two more such reinfection cases in Lombardy residents that, nevertheless the ECDC …
[HTML][HTML] Características clínicas de COVID-19 en trabajadores sanitarios de tres hospitales de Madrid durante la primera ola de la pandemia
Á Deschamps-Perdomo, M Garrafa-Núñez… - Medicina y seguridad …, 2021 - SciELO Espana
Introducción: El objetivo Disminuir el área de incertidumbre con la comprensión de la
sintomatología y la caracterización clínica dentro del entorno hospitalario. Método: Este es …
sintomatología y la caracterización clínica dentro del entorno hospitalario. Método: Este es …
Estimating the spreading and dominance of SARS-CoV-2 VOC 202012/01 (lineage B. 1.1. 7) across Europe
We develop a two strain, age-structured, compartmental model to assess the spreading
potential of the B. 1.1. 7 variant across several European metropolitan areas and countries …
potential of the B. 1.1. 7 variant across several European metropolitan areas and countries …
Early assessment of epidemiological trends associated with SARS-CoV-2 variants of concern in Germany
Growing evidence on higher transmissibility of novel variants of the SARS-CoV-2
coronavirus is raising alarm in many countries. We provide near-time estimates of the …
coronavirus is raising alarm in many countries. We provide near-time estimates of the …
Early estimates of SARS-CoV-2 B. 1.1. 7 variant emergence in a university setting
Recent identification of the highly transmissible novel SARS-CoV-2 variant in the United
Kingdom (B. 1.1. 7) has raised concerns for renewed pandemic surges worldwide,. B. 1.1. 7 …
Kingdom (B. 1.1. 7) has raised concerns for renewed pandemic surges worldwide,. B. 1.1. 7 …
How Antivirals Might be Linked to the Emergence of New Variants of SARS-CoV-2
AR Mehdizadeh, JJ Bevelacqua… - Journal of Biomedical …, 2021 - jbpe.sums.ac.ir
SARS-CoV-2, the virus that caused COVID-19 pandemic, is spreading fast around the globe.
As of January 24, 2021, this world health threat has affected more than 96 million people …
As of January 24, 2021, this world health threat has affected more than 96 million people …